Correlation Between TaiMed Biologics and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TaiMed Biologics and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TaiMed Biologics and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TaiMed Biologics and Medigen Vaccine Biologics, you can compare the effects of market volatilities on TaiMed Biologics and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TaiMed Biologics with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of TaiMed Biologics and Medigen Vaccine.

Diversification Opportunities for TaiMed Biologics and Medigen Vaccine

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between TaiMed and Medigen is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding TaiMed Biologics and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and TaiMed Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TaiMed Biologics are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of TaiMed Biologics i.e., TaiMed Biologics and Medigen Vaccine go up and down completely randomly.

Pair Corralation between TaiMed Biologics and Medigen Vaccine

Assuming the 90 days trading horizon TaiMed Biologics is expected to generate 1.11 times more return on investment than Medigen Vaccine. However, TaiMed Biologics is 1.11 times more volatile than Medigen Vaccine Biologics. It trades about 0.05 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about -0.19 per unit of risk. If you would invest  8,280  in TaiMed Biologics on September 2, 2024 and sell it today you would earn a total of  150.00  from holding TaiMed Biologics or generate 1.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

TaiMed Biologics  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
TaiMed Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TaiMed Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, TaiMed Biologics is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

TaiMed Biologics and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TaiMed Biologics and Medigen Vaccine

The main advantage of trading using opposite TaiMed Biologics and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TaiMed Biologics position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind TaiMed Biologics and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine